PPT-Provider Adherence to Oral Chemotherapy Dose Adjustment Guidelines
Author : alida-meadow | Published Date : 2018-12-04
UT Clinical Safety amp Effectiveness Conference San Antonio TX October 2728 2011 Amy Fowler MD Alexis Kennedy CPNP Naomi Winick MD The Team Team Members CSampE
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Provider Adherence to Oral Chemotherapy ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Provider Adherence to Oral Chemotherapy Dose Adjustment Guidelines: Transcript
UT Clinical Safety amp Effectiveness Conference San Antonio TX October 2728 2011 Amy Fowler MD Alexis Kennedy CPNP Naomi Winick MD The Team Team Members CSampE Participants Amy Fowler MD Project Leader. Maggie Charpentier, PharmD, BCPS. Clinical Associate Professor University of Rhode Island. Per-diem pharmacist: Roger Williams Medical Center. Goal and Objectives. Goal:. Educate pharmacists regarding counseling and safe dispensing of oral chemotherapy in community pharmacy. Cory Theberge, PhD. UNE College of Pharmacy. Karin Wagner, DVM, DACVIM. Maine Veterinary Referral Center. Scarborough, ME . Learning Objectives . Relate the types of cancers seen in cats and dogs, and recall oral chemotherapy dosing and treatment strategies. cyclophosphamide price increase. Genesee St.) will be up for sale. cytoxan taxotere. oral cytoxan. cyclophosphamide order set. oral cytoxan antiemetic. oral cytoxan for ovarian cancer. cytoxan oral cost. Program Goals. The Importance of Controlling Nausea and Vomiting in the Setting of Chemotherapy. CINV: Consequences. Emetogenicity of IV Chemotherapy. Emetogenicity of Oral Chemotherapy. Types of CINV. Simi Padival, MD. November 3, 2016. Objectives. Learn about the importance of assessing adherence to antiretroviral therapy (ART). Learn about the components of assessing for ART adherence. Discuss frequency of monitoring while on ART. PrEP. Version. : December . 2018. Outline of training. Module 1: Introduction to oral PrEP. Oral PrEP: the basics. What is combination prevention?. How effective is oral PrEP? . What are the differences among PrEP, PEP, and ART? . ON ORAL . PrEP. Version. : December 2018. Initiation and clinical management of PrEP for AGYW . Note for facilitator: Initiation, follow-up, and maintenance of PrEP for . AGYW should follow the same procedures as that of PrEP for adults. . By : . Manal. . Mostafa. . Saleh. Demonstrator of clinical oncology , Nuclear medicine. References :. Physicians Cancer Chemotherapy Drug Manual (2015).. 2013-ESMO-Handbook-of-Cancer-Treatments-in-Special-Clinical-Situations.. CRRT BackgroundWhena patient is initiated on CRRT antimicrobial therapy often requires adjustment to ensure adequate drug concentrations are achievedCVVHDremoves solutes including drugs via diffusion . Dr. N.M. ABDUL KHADER JAILANI. Objectives. . To characterize the most common toxicities of conventional chemotherapy. To describe the relationship between the mechanism of action of a chemotherapy drug and its associated toxicities. Marika Rasschaert MD . Senior Staff – Department of Oncology - MOCA. University Hospital Antwerp, Belgium. Development and Implementation. Relevant Financial Relationship. None. Off-label Investigational Uses. Infection. If you have a fever or are feeling sick, your chemotherapy may be delayed . This is done for your safety, so you can recover from the infection. If your dose of chemotherapy causes side Alliance Anti - emetic Guidelines for Chemotherapy Induced Nausea and Vomiting ( CINV ) Adult Oncology & Haematology Document Control Document Title: Antiemetic Guidelines for CINV NESCN v2.2 Jan 201 . TNT. SIMPLIFIED STAGING. STAGE I NO LYMPH NODE, SMALL TUMOR. STAGE II NO LYMPH NODE, INVADES SUBSEROSA. STAGE III LYMPH NODES with cancer. STAGE IV Distant METASTASIS. FOCUS FOR TODAY IS STAGE II AND III RECTAL CANCER.
Download Document
Here is the link to download the presentation.
"Provider Adherence to Oral Chemotherapy Dose Adjustment Guidelines"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents